Amino.Desk

Survodutide

Updated Nov 17, 2026 · Clinical review: pending

Survodutide is an experimental weekly weight-loss injection from Boehringer Ingelheim and Zealand Pharma. It has finished several Phase 3 trials but, as of November 2026, is not approved for any use.

What it is

Survodutide activates two receptors, GLP-1 and glucagon, the same pairing as mazdutide. The glucagon side is meant to increase fat burning in the liver, which is why it is also being tested in liver disease.

What the evidence shows

These are large, well-run trials. The grade is B because the drug is not approved and its weight loss is smaller than the approved tirzepatide in separate trials.

Dosing used in the trials

There is no approved dose. Trials gave survodutide once a week and raised the dose gradually to a maintenance dose of 3.6 mg or 6.0 mg. The dose-raising period is where most side effects and dropouts happened, and newer trials use slower, more flexible schedules.

Side effects

Legal status

Survodutide is not approved for any use. The FDA has named it among the drugs it has warned research-chemical sellers about.

Common questions

Is survodutide approved?

No. As of November 2026 it is not approved for any use in any country.

How much weight did people lose on survodutide?

In SYNCHRONIZE-1, average weight loss over 76 weeks was 12.2% on 3.6 mg and 13.0% on 6.0 mg, against 5.4% on placebo.

What are the side effects of survodutide?

Stomach and gut side effects were very common: 81% on 3.6 mg and 90% on 6.0 mg in SYNCHRONIZE-1, against 48% on placebo, mostly mild to moderate.

Added in the latest update. These answers summarize the sections above; sources are listed below.

Ask an AI about this page

Opens the assistant with a question about this page already typed in. You can edit it before sending.

Ask ChatGPTAsk ClaudeAsk Perplexity

These are outside services. Amino Desk does not control or review their answers, and an AI summary is not medical advice. Check anything important against the sources below.

Sources

Free field guide

Forty peptides and GLP-1s: who can legally get what, how strong the evidence is, and what to check before you pay. Plus one short email a week on what changed.

Leave at any time. We do not sell or share your address. Privacy